KELLY CAMPBELL-WIGINGTON: Open Payments
NPI 1275813719 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 7 payments from 6 companies in 2025. Trend: 2023 $216 · 2024 $586 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $260 |
| Biogen, Inc. | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| ABBVIE INC. | 1 | $90 |
| Getinge USA Sales, LLC | 1 | $81 |
| Lundbeck LLC | 1 | $25 |
Products named: CAPLYTA, REXULTI, ZURZUVAE, VRAYLAR, VASOVIEW HEMOPRO 2.
Industry payments across NY — which companies pay providers there.
